Hemoglobin and Iron Recovery Study
HEIRS
1 other identifier
interventional
215
1 country
4
Brief Summary
The purpose of this study is to investigate the effect of daily iron supplements after blood donation on time to recovery of hemoglobin and iron stores. The study will also determine whether the effect of iron supplements on time to recovery is different in men and women, in older vs. younger donors (\<60 years old vs. at least 60 years old) and in donors with replete vs. diminished pre-donation iron stores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Mar 2012
Shorter than P25 for phase_2
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 9, 2012
CompletedFirst Posted
Study publicly available on registry
March 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJanuary 23, 2014
January 1, 2014
1.2 years
March 9, 2012
January 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to recovery of hemoglobin after blood donation
Hemoglobin will be measured 3-7 days and 2, 4, 8, 12, 16 and 24 weeks after blood donation. A nonlinear regression of hemoglobin vs time since donation will be used to determine time to recovery of hemoglobin to 80% of the pre-donation level.
Up to 24 weeks after blood donation
Secondary Outcomes (2)
Iron stores
Up to 24 weeks after blood donation
Total body iron
24 weeks after blood donation
Study Arms (2)
Iron supplements
EXPERIMENTALSubjects who are randomized to receive daily iron supplements after donating blood
Control
NO INTERVENTIONSubjects who are randomized not to receive daily iron supplements after donating blood
Interventions
daily capsule of ferrous gluconate containing 38 mg of elemental iron
Eligibility Criteria
You may qualify if:
- potential blood donors with hemoglobin of at least 12.5 gm/dL
- no blood donation for at least 4 months
- successful donation of a unit of whole blood
You may not qualify if:
- individuals who are taking iron supplements including multivitamins containing iron and refuse to stop do so for the 24 weeks of the study.
- baseline ferritin \>300 ug/L (to exclude individuals with hemochromatosis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)lead
- Institute for Transfusion Medicinecollaborator
- Versiti Blood Healthcollaborator
- Blood Centers of the Pacificcollaborator
- American National Red Crosscollaborator
- University of California, San Franciscocollaborator
- Vitalant Research Institutecollaborator
- RTI Internationalcollaborator
Study Sites (4)
Blood Centers of the Pacific
San Francisco, California, 94118, United States
American Red Cross, Connecticut Region
Farmington, Connecticut, 06032, United States
Institute for Transfusion Medicine
Pittsburgh, Pennsylvania, 15213, United States
Blood Center of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Related Publications (3)
Mast AE, Szabo A, Stone M, Cable RG, Spencer BR, Kiss JE; NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III. The benefits of iron supplementation following blood donation vary with baseline iron status. Am J Hematol. 2020 Jul;95(7):784-791. doi: 10.1002/ajh.25800. Epub 2020 Apr 15.
PMID: 32243609DERIVEDCable RG, Brambilla D, Glynn SA, Kleinman S, Mast AE, Spencer BR, Stone M, Kiss JE; National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Effect of iron supplementation on iron stores and total body iron after whole blood donation. Transfusion. 2016 Aug;56(8):2005-12. doi: 10.1111/trf.13659. Epub 2016 May 27.
PMID: 27232535DERIVEDKiss JE, Brambilla D, Glynn SA, Mast AE, Spencer BR, Stone M, Kleinman SH, Cable RG; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Oral iron supplementation after blood donation: a randomized clinical trial. JAMA. 2015 Feb 10;313(6):575-83. doi: 10.1001/jama.2015.119.
PMID: 25668261DERIVED
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Joe Kiss, MD
Institute for Transfusion Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2012
First Posted
March 15, 2012
Study Start
March 1, 2012
Primary Completion
May 1, 2013
Study Completion
June 1, 2013
Last Updated
January 23, 2014
Record last verified: 2014-01